Cytolysis of Fibroblasts by C3a

Overview

Journal Br J Cancer

Specialty Oncology

Date 1980 Jul 1

PMID 7426327

Authors

A Temple

A C Allison

Affiliations

Soon will be listed here.

Abstract

C3a was found to be more cytolytic to transformed than to primary fibroblast cultures from mouse and man. Fibroblasts made quiescent with caffeine were lysed by the same concentrations of C3a as untreated cells. These findings may have implications in tumour immunity.

References

da Silva W, Eisele J, Lepow I . Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3. J Exp Med. 1967; 126(6):1027-48. PMC: 2138425. DOI: 10.1084/jem.126.6.1027. View

Cochrane C, MULLER-EBERHARD H . The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med. 1968; 127(2):371-86. PMC: 2138443. DOI: 10.1084/jem.127.2.371. View

Bokisch V, MULLER-EBERHARD H . Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest. 1970; 49(12):2427-36. PMC: 322744. DOI: 10.1172/JCI106462. View

Bitter-Suermann D, HADDING U, Melchert F, WELLENSIEK H . Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5. Immunochemistry. 1970; 7(12):955-65. DOI: 10.1016/0019-2791(70)90002-9. View

Wuepper K, Bokisch V, MULLER-EBERHARD H, Stoughton R . Cutaneous responses to human C 3 anaphylatoxin in man. Clin Exp Immunol. 1972; 11(1):13-20. PMC: 1553684. View

Lai A Fat R, Van Furth R . In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology. 1975; 28(2):359-68. PMC: 1445813. View

Nicholson A, Brade V, Schorlemmer H, Burger R, Bitter-Suermann D, HADDING U . Interaction of C3b, B, and D in the alternative pathway of complement activation. J Immunol. 1975; 115(4):1108-13. View

Pardee A, James L . Selective killing of transformed baby hamster kidney (BHK) cells. Proc Natl Acad Sci U S A. 1975; 72(12):4994-8. PMC: 388861. DOI: 10.1073/pnas.72.12.4994. View

Schorlemmer H, Davies P, Allison A . Ability of activated complement components to induce lysosomal enzyme release from macrophages. Nature. 1976; 261(5555):48-9. DOI: 10.1038/261048a0. View

10.

Nicolson G . Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim Biophys Acta. 1976; 458(1):1-72. DOI: 10.1016/0304-419x(76)90014-7. View

11.

Bentley C, Bitter-Suermann D, HADDING U, Brade V . In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages. Eur J Immunol. 1976; 6(6):393-8. DOI: 10.1002/eji.1830060604. View

12.

Schorlemmer H, Allison A . Effects of activated complement components on enzyme secretion by macrophages. Immunology. 1976; 31(5):781-8. PMC: 1445134. View

13.

FERLUGA J, Schorlemmer H, Baptista L, Allison A . Cytolytic effects of the complement cleavage product, C3a. Br J Cancer. 1976; 34(6):626-34. PMC: 2025225. DOI: 10.1038/bjc.1976.223. View

14.

FERLUGA J, Schorlemmer H, Baptista L, Allison A . Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects. Clin Exp Immunol. 1978; 31(3):512-7. PMC: 1541251. View

15.

Goodman M, Weigle W, Hugli T . Inability of the C3a anaphylatoxin to promote cellular lysis. Nature. 1980; 283(5742):78-80. DOI: 10.1038/283078a0. View